Mai Capital Management Amgen Inc Transaction History

Mai Capital Management

$9.87 Billion
Q2 2024

A detailed history of Mai Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Mai Capital Management holds 45,293 shares of AMGN stock, worth $14.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

45,293

Previous 45,774 1.05%

Holding current value

$14.3 Million

Previous $13 Million 8.74%

% of portfolio

0.14%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $126,382 - $153,588	-481 Reduced 1.05%	45,293 $14.2 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $1.86 Million - $2.25 Million	6,933 Added 17.85%	45,774 $13 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $4,858 - $5,480	19 Added 0.05%	38,841 $11.2 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $122,225 - $151,746	559 Added 1.46%	38,822 $10.4 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $242,339 - $286,561	-1,131 Reduced 2.87%	38,263 $8.5 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $416,130 - $507,193	-1,843 Reduced 4.47%	39,394 $9.52 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $110,850 - $140,848	-484 Reduced 1.16%	41,237 $10.8 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $2.13 Million - $2.4 Million	9,496 Added 29.47%	41,721 $9.4 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $287,464 - $319,898	-1,246 Reduced 3.72%	32,225 $7.84 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $320,353 - $354,394	-1,461 Reduced 4.18%	33,471 $8.09 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $7.67 Million - $8.78 Million	-38,571 Reduced 52.48%	34,932 $7.86 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $669,287 - $784,151	3,153 Added 4.48%	73,503 $15.6 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $6,540 - $7,255	28 Added 0.04%	70,350 $17.1 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $2.79 Million - $3.25 Million	-12,562 Reduced 15.16%	70,322 $17.5 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $365,249 - $434,946	1,688 Added 2.08%	82,884 $19.1 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $31,677 - $35,228	-135 Reduced 0.17%	81,196 $20.6 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $379,795 - $466,060	1,920 Added 2.42%	81,331 $19.2 Million
Q1 2020 Apr 16, 2020	BUY	$182.24 - $241.7 $534,145 - $708,422	2,931 Added 3.83%	79,411 $16.1 Million
Q4 2019 Feb 03, 2020	BUY	$189.21 - $243.2 $164,423 - $211,340	869 Added 1.15%	76,480 $18.4 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $420,127 - $503,400	-2,413 Reduced 3.09%	75,611 $14.6 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $12,669 - $14,851	76 Added 0.1%	78,024 $14.4 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $261,538 - $294,810	1,446 Added 1.89%	77,948 $14.8 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $723,768 - $844,870	4,057 Added 5.6%	76,502 $14.9 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $98,944 - $111,547	-534 Reduced 0.73%	72,445 $15 Million
Q2 2018 Aug 16, 2018	BUY	$166.05 - $186.51 $251,399 - $282,376	1,514 Added 2.12%	72,979 $13.5 Million
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $124,531 - $145,530	735 Added 1.04%	71,465 $12.2 Million
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $538,946 - $602,167	-3,193 Reduced 4.32%	70,730 $12.3 Million
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $31,952 - $36,481	191 Added 0.26%	73,923 $13.8 Million
Q2 2017 Aug 07, 2017	BUY	N/A	73,732	73,732 $12.7 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Amgen Inc Transaction History